Johnson Booster 85% Effective Against Omicron: South Africa Study

The New Diplomat
Writer

Ad

From Aid to Algorithms: How Africa Can Lead Its Own AI Revolution

By Sonny Iroche As a participant and delegate at three of the world’s most defining Artificial Intelligence summits, from Doha to Paris and Kigali , I have had the privilege of engaging directly with global policymakers, innovators, and technology leaders shaping the future of AI. Although I was unable to attend the first global AI…

King Charles, Pope Leo pray together in historic first

King Charles III on Thursday became the first head of the Church of England to pray publicly with a pope since the schism with Rome 500 years ago, in a service led by Leo XIV. The 76-year-old monarch and his wife, Queen Camilla, joined the US-born pope in the Sistine Chapel for a 30-minute service…

Tears as Ghana’s Ex-First Lady Nana Konadu Rawlings Dies at 76

By Abiola Olawale Ghana is shrouded in grief on Thursday, October 23, 2025, following the passing of a former First Lady, Nana Konadu Agyeman-Rawlings, who died at the age of 76 in Accra. ​Sources close to the family confirmed that the former First Lady, the widow of the late President Jerry John Rawlings, passed away…

Ad

AFP — A booster of US coronavirus vaccine Johnson & Johnson was 85 percent effective in preventing serious illness in areas where Omicron was dominant, a South African trial study indicated Thursday.

The South African Medical Research Council conducted the study on health workers from November 15 to December 20, but it has still not been peer-reviewed.

It found the top-up jab to largely protect staff in a country where the highly transmissible strain is now behind most Covid cases.

“Data from the… study confirm that the Johnson & Johnson COVID-19 booster shot provides 85 percent effectiveness against hospitalization in areas where Omicron is dominant,” Johnson & Johnson said.

“This adds to our growing body of evidence which shows that the effectiveness of the Johnson & Johnson Covid-19 vaccine remains strong and stable over time, including against circulating variants such as Omicron and Delta,” it said.

Around half a million South African health staff have received Johnson jabs as part of clinical trials.

Africa’s hardest-hit country, South Africa has recorded more than 3.4 million cases and 90,000 deaths since the start of the pandemic.

An earlier South African study in December found the Pfizer/BioNTech vaccine to be less effective overall against Omicron, but still prevented hospital admissions by up to 70 percent.

Ad

X whatsapp